スタチンの世界市場:ロバスタチン、プラバスタチン、シンバスタチン、アトルバスタチン、フルバスタチン、ロスバスタチン

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR6430)
◆英語タイトル:Global Statin Market 2015-2019
◆発行会社/調査会社:Technavio
◆商品コード:IRTNTR6430
◆発行日:2015年7月8日
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:81
◆レポート言語:英語
◆レポート形式:pdf
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[スタチンの世界市場:ロバスタチン、プラバスタチン、シンバスタチン、アトルバスタチン、フルバスタチン、ロスバスタチン]についてメールでお問い合わせはこちら
当調査レポートでは、スタチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、スタチンの世界市場規模及び予測、製品別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
*** レポート概要(サマリー)***

About Statin
Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality. It has significant anti-inflammatory and plaque-stabilizing effects. Its other effects include decreased oxidative stress and vascular inflammation with increased atherosclerotic lesions. Some of the currently available statins are atorvastatin, lovastatin, rosuvastatin, and simvastatin.

Technavio’s analysts forecast the global statin market to decline at a CAGR of 7.50% over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the global statin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of statins used for the management of lipid abnormalities and lipid-associated comorbidities such as stroke and coronary heart disease. This report provides a discussion of the market in the following three regions: Americas, APAC, and EMEA.

Technavio’s report, Global Statin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• AstraZeneca
• Merck
• Novartis
• Pfizer

[Other Prominent Vendors]
• Amgen
• Aurobindo Pharma
• Abbvie
• Abbott
• Biocon
• BC World Pharm
• Cipla
• Concord Biotech
• CKD Bio
• CJ HealthCare Corporation
• Cerenis Therapeutics
• GlaxoSmithKline
• HanAll BioPharma
• JX Pharmaceuticals
• Kowa
• Lupin
• Livzon
• Mylan
• Merz Pharmaceuticals
• SUN Pharma
• Teva
• Torrent Pharmaceuticals
• Zydus Cadila

[Market Driver]
• Rising Number of High Cholesterol Cases
• For a full, detailed list, view our report

[Market Challenge]
• Lack of Novel Molecules in Statins Category
• For a full, detailed list, view our report

[Market Trend]
• Switch from Statins to Non-statins
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

*** レポート目次(コンテンツ)***

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Product Profile
05.1 Crestor
05.2 Caduet
05.3 Lescol
05.4 Lipitor
05.5 Liptruzet
05.6 Mevacor
05.7 Vytorin
05.8 Zocor

06.Introduction

07.Statin: An Overview
07.1 Statin Pharmacophore
07.2 Mechanism of Action
07.2.1 Different Class of Lipoproteins
07.3 Clinical Application
07.4 Treatment Guidelines

08.Pipeline Portfolio
08.1 HL040
08.2 Livasartan
08.3 BCWP-C001
08.4 CJ-30056

09.Market Landscape
09.1 Market Overview
09.1.1 Market Size and Forecast
09.2 Statin Market in US 2014-2019
09.2.1 Market Size and Forecast
09.3 Five Forces Analysis

10.Market Segmentation by Product Category
10.1 Type 1 Statins
10.1.1 Lovastatin
10.1.2 Pravastatin
10.1.3 Simvastatin
10.2 Type 2 Statins
10.2.1 Atorvastatin
10.2.2 Fluvastatin
10.2.3 Rosuvastatin

11.Geographical Segmentation
11.1 Global Statin Market by Geographical Segmentation 2014-2019

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 AstraZeneca
19.2.2 Merck
19.2.3 Novartis
19.2.4 Pfizer
19.3 Other Prominent Vendors

20.Key Vendor Analysis
20.1 AstraZeneca
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Business Segmentation by Revenue 2011-2013
20.1.5 Sales by Geography
20.1.6 Business Strategy
20.1.7 Key Developments
20.1.8 SWOT Analysis
20.2 Merck
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Sales by Geography
20.2.6 Business Strategy
20.2.7 Key Developments
20.2.8 SWOT Analysis
20.3 Novartis
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison 2012 and 2013
20.3.6 Sales by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Pfizer
20.4.1 Key facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Key Developments
20.4.8 SWOT Analysis

21.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Pictorial Representation of Statin Pharmacophore
Exhibit 3: Schematic Representation of Statin and Effect on Cholesterol Synthesis
Exhibit 4: Evaluation of Lipoprotein Levels based on ATP III Classification
Exhibit 5: Diagrammatic Representation of Pipeline Molecules for Lipid Management
Exhibit 6: Global Statin Market 2014-2019 ($ millions)
Exhibit 7: Statin Market in US 2014-2019 ($ millions)
Exhibit 8: Global Statin Market Segmentation by Molecule Type
Exhibit 9: Segmentation of Global Statin Market by Geography 2014
Exhibit 10: Arguments For and Against OTC Switch by Pharmaceutical Companies and Regulatory Organizations
Exhibit 11: Crestor: YoY Global Revenue 2010-2014 ($ millions)
Exhibit 12: AstraZeneca: Key Takeaways
Exhibit 13: Vytorin: YoY Global Revenue of 2010-2014 ($ millions)
Exhibit 14: Zocor: YoY Global Revenue 2010-2014 ($ millions)
Exhibit 15: Merck: Key Takeaways
Exhibit 16: Lipitor: YoY Global Revenue of 2010-2014 ($ millions)
Exhibit 17: Pfizer: Key Takeaways
Exhibit 18: AstraZeneca: Business Segmentation by Revenue 2013
Exhibit 19: AstraZeneca: Business Segmentation by Revenue 2011-2013 ($ millions)
Exhibit 20: AstraZeneca: Sales by Geography 2013
Exhibit 21: Merck: Business Segmentation by Revenue 2013
Exhibit 22: Merck: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 23: Merck: Sales by Geography 2013
Exhibit 24: Novartis: Business Segmentation
Exhibit 25: Novartis: Revenue by Business Segmentation 2013
Exhibit 26: Novartis: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 27: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 28: Pfizer: Business Segmentation by Revenue 2014
Exhibit 29: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 30: Pfizer: Geographical Segmentation by Revenue 2014



*** 掲載企業 ***

AstraZeneca, Merck, Novartis, Pfizer, Amgen, Aurobindo Pharma, Abbvie, Abbott, Biocon, BC World Pharm, Cipla, Concord Biotech, CKD Bio, CJ HealthCare Corporation, Cerenis Therapeutics, GlaxoSmithKline, HanAll BioPharma, JX Pharmaceuticals, Kowa, Lupin, Livzon, Mylan, Merz Pharmaceuticals, SUN Pharma, Teva, Torrent Pharmaceuticals, Zydus Cadila

*** レポートのキーワード ***

スタチン、酵素、薬剤、ロバスタチン、プラバスタチン、シンバスタチン、アトルバスタチン、フルバスタチン、ロスバスタチン、HL040、Livasartan、BCWP-C001、CJ-30056

*** 調査方法 ***

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ドイツにおけるペット保険に関する消費者意識:Pet Metrics: Consumer Approaches to Pet Insurance in Germany
    Finaccord’s report titled Pet Metrics: Consumer Approaches to Pet Insurance in Germany offers detailed and unique insights into the behaviour of pet owners in the context of pet insurance in Germany. Based on a primary survey of over 1,000 consumers in Germany carried out in July and August 2008, th …
  • ABBV – Pharmaceutical Manufacturing Plant – シンガポールの建設プロジェクト概要
    World Market Intelligence's "ABBV – Pharmaceutical Manufacturing Plant – Singapore - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the ABBV – Pharmaceutical Manufacturing Plant – Singapore construction project. World Ma …
  • 世界及び中国のジ(2-エチルヘキシル)アミン市場2016
    The 'Global and Chinese Di-2-Ethylhexylamine Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Di-2-Ethylhexylamine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Di-2-Ethylhexyl …
  • 切削刃具の世界市場
    In this report, the global Cutting Tool Blade market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenu …
  • 連続溶接パイプの世界市場
    Continuous Welded Pipes Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States …
  • Entergy Gulf States Louisiana, L.L.C.(代替エネルギー分野):企業M&A動向
    Summary Entergy Gulf States Louisiana, L.L.C. (Entergy Gulf States) is an energy utility service provider. The company provides power distribution and related services to the residential and business customers. Its services include distribution, electrical and gas safety, payments and billing, energ …
  • タイのペット用食品市場(Animal Food Market in Thailand)
    This market research report offers a perspective on the actual market situation, trends and future outlook for animal food in Thailand. The study provides essential market information for decision-makers including: - Overall market for animal food in Thailand - Market for animal food by type - Forec …
  • 空気清浄機フィルターの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Air Purifier Filter Revenue, means the sales value of Air Purifier Filter This report studies sales (consumption) of Air Purifier Filter in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, w …
  • L&F(L&F CO., LTD)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 円形編み機の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Scope of the Report: This report focuses on the Circular Knitting Machine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufac …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR6430 )"スタチンの世界市場:ロバスタチン、プラバスタチン、シンバスタチン、アトルバスタチン、フルバスタチン、ロスバスタチン" (英文:Global Statin Market 2015-2019 )はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。